Axsome Therapeutics AXSM
NASDAQ AXSM
$206.82 -1.53 (-0.73%)
As of: Sep 4, 2026 · 3:59 PM EDT

Axsome Therapeutics (AXSM) Property, Plant & Equipment (Net) (2015 - 2026)

Analysis

Axsome Therapeutics (AXSM) Property, Plant & Equipment (Net) (2015 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 2.06 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 34.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.64 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 554.14 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 107.22 Mn
10 Axsome Therapeutics 10.75 Bn 10.43 Bn 204.81 Mn 874,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 874,000.00
Mar 31, 2026 567,000.00
Dec 31, 2025 562,000.00
Sep 30, 2025 605,000.00
Jun 30, 2025 667,000.00
Mar 31, 2025 773,000.00
Dec 31, 2024 584,000.00
Sep 30, 2024 683,000.00
Jun 30, 2024 724,000.00
Mar 31, 2024 812,000.00
Dec 31, 2023 846,000.00
Sep 30, 2023 971,000.00
Jun 30, 2023 736,000.00
Mar 31, 2023 703,000.00
Dec 31, 2022 722,000.00
Sep 30, 2022 626,990.00
Jun 30, 2022 634,611.00
Mar 31, 2022 460,946.00
Dec 31, 2021 283,846.00
Sep 30, 2021 314,891.00